Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
Inaxaplin is an apolipoprotein L1 (ApoL1) inhibitor.1 It inhibits cytotoxicity induced by overexpression of the APOL1 variants G1 and G2 in cells when used at a concentration of 3 µM. Inaxaplin also reduces ApoL1 G1-induced inhibition of global protein synthesis in podocytes isolated from APOL1 transgenic mice. In vivo, inaxaplin (10 mg/kg) reduces podocyte injury and proteinuria in APOL1 transgenic mice.
WARNING This product is not for human or veterinary use.
1. APOL1-